Articles published by Mind Medicine

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

December 11, 2024

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)

June 20, 2024

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed to Present at Upcoming April Medical Conferences

April 02, 2024

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

December 14, 2023

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed Reports Third Quarter 2023 Financial Results and Business Highlights

November 02, 2023

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed Announces Election of All Six Company Nominees at Annual Meeting

June 21, 2023

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed Provides Overview of Clinical Progress and Corporate Updates at Investor Day

June 20, 2023

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed Adjourns Annual General Meeting of Shareholders

June 15, 2023

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed to Host Investor Day June 2023

June 07, 2023

From Mind Medicine

Via Business Wire

Tickers MNMD

MindMed to Participate at Upcoming Investor Conferences

June 01, 2023

From Mind Medicine

Via Business Wire

Tickers MNMD

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.